Table 3 Comparison of clinical characteristics in high SOCS5 patients with the pringle maneuver time less than or over 15 min*.
Characteristics | Pringle maneuver time <15 min | Pringle maneuver time ≥15 min | p value |
|---|---|---|---|
N | 40 (64.5) | 22 (35.4) | |
Age, years | 0.72a | ||
≤60 | 29 (72.5) | 15 (68.2) | |
>60 | 11 (27.5) | 7 (31.8) | |
Sex | 0.238b | ||
Male | 30 (75.0) | 20 (90.9) | |
Female | 10 (25.0) | 2 (9.1) | |
HBsAg | 0.546c | ||
Negative | 39 (7.5) | 0 (0.0) | |
Positive | 37 (92.5) | 22 (1.0) | |
Cirrhosis | 0.821a | ||
Yes | 28 (70.0) | 16 (72.7) | |
No | 12 (30.0) | 6(27.3) | |
AFP, ng/ml | 0.419a | ||
≤400 | 26 (65.0) | 12 (54.5) | |
>400 | 14 (35.0) | 10 (45.5) | |
Tumor size, cm | 4 (2.63–6.38) | 5.88 (33.88–7.13) | 0.068d |
Tumor number | 0.159b | ||
Solidary | 36 (90.0) | 16 (72.7) | |
Multiple | 4 (10.0) | 6 (27.3) | |
Microvascular invasion | 0.533a | ||
Yes | 14 (35.0) | 6 (27.3) | |
No | 26 (65.0) | 16 (72.7) | |
Macroscopic vascular invasion | 0.159b | ||
Yes | 4 (10.0) | 6 (27.3) | |
No | 36 (90.0) | 16 (72.7) | |
Tumor capsule | 0.188b | ||
Yes | 3 (7.5) | 5 (22.7) | |
No | 37 (92.5) | 17 (77.3) | |
Tumor differentiation | 1b | ||
I-II | 35 (87.5) | 19 (86.4) | |
III-IV | 5 (12.5) | 3 (13.6) | |
Steatosis | 1c | ||
Yes | 2 (5.0) | 1(4.5) | |
No | 38 (95.0) | 21 (95.5) | |
Blood loss, ml | 200 (100–375) | 200 (200–550) | 0.057d |
Blood transfusion | 0.601b | ||
Yes | 4 (10.0) | 4 (18.2) | |
No | 36 (90.0) | 18 (81.8) |